CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −1,355 | $519.67 | $704K | 25,797 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −308 | $520.68 | $160K | 25,489 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −1,094 | $521.79 | $571K | 24,395 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −1,434 | $522.70 | $750K | 22,961 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −811 | $523.66 | $425K | 22,150 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −153 | $524.49 | $80K | 21,997 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −120 | $526.68 | $63K | 21,877 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −200 | $527.85 | $106K | 21,677 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −440 | $528.60 | $233K | 21,237 |
| 2025-11-13 | Levy Richard S Director | Sale 10b5-1 | −40 | $530.21 | $21K | 21,197 |
| 2025-11-13 | Levy Richard S Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,500 | 2,500 | ||
| 2025-11-13 | Levy Richard S Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 4,000 | ||
| 2025-11-05 | BATE KENNETH Director | Option exercise | +5,470 | $9.45 | $52K | 8,097 |
| 2025-11-05 | BATE KENNETH Director | Option exercise | +10,000 | $303.79 | $3.0M | 18,097 |
| 2025-11-05 | BATE KENNETH Director | Option exercise | +1,105 | $280.04 | $309K | 19,202 |
| 2025-11-05 | BATE KENNETH Director | Sale | −1,763 | $480.24 | $847K | 17,439 |
| 2025-11-05 | BATE KENNETH Director | Sale | −3,259 | $481.13 | $1.6M | 14,180 |
| 2025-11-05 | BATE KENNETH Director | Sale | −1,284 | $482.41 | $619K | 12,896 |
| 2025-11-05 | BATE KENNETH Director | Sale | −2,069 | $483.41 | $1.0M | 10,827 |
| 2025-11-05 | BATE KENNETH Director | Sale | −1,931 | $484.78 | $936K | 8,896 |
Page 13 of 82 · 1,629 trades